Abstract: A voice lamp includes a radiator, a voice input module, a light emitting assembly, a diffusion cover and a sound guiding tube. The voice input module is electrically connected to the light emitting assembly, and the voice input module and the light emitting assembly are both arranged in the radiator; the diffusion cover is connected to the radiator and covers the outside of the light emitting end of the light emitting assembly; the sound guiding tube is provided through the diffusion cover in the axial direction of the radiator, and the sound guiding tube is directly opposed to the voice input module. According to the application, the sound receiving effect can be improved due to the provision of the sound guiding tube.

Abstract: A current sensing technique for coupled inductors in switching regulator circuits, where the current sensing technique can provide the current information needed for a power converter design and can be implemented as a real-world solution. The current sensing techniques can provide complete information of the coupled inductor current, such as peak current, valley current, and intermediate ripples. The current sensing techniques can use a simple RC network, such as two resistors and two capacitors for 2-phase operation. The techniques, however, are not limited to two-phase operation. The current sensing techniques of this disclosure can be extended to power stage assembly implementations, e.g., DrMOS modules, with current output in order to increase signal-to-noise ratio, which is significant for reliable control. in addition, the current sensing techniques of this disclosure can be extended to multi-phase operation, such as three or more phases.

Abstract: An out-of-order buffer includes an out-of-order queue and a controlling circuit. The out-of-order queue includes a request sequence table and a request storage device. The controlling circuit receives and temporarily stores the plural requests into the out-of-order queue. After the plural requests are transmitted to plural corresponding target devices, the controlling circuit retires the plural requests. The request sequence table contains m×n indicating units. The request sequence table contains m entry indicating rows. Each of the m entry indicating rows contains n indicating units. The request storage device includes m storage units corresponding to the m entry indicating rows in the request sequence table. The state of indicating whether one request is stored in the corresponding storage unit of the m storage units is recoded in the request sequence table. The storage sequence of the plural requests is recoded in the request sequence table.

Abstract: A method for treating an autoimmune neurological disease and/or a neurodegenerative disease is provided. The method includes administering an effective amount of at least one compound having Formula (I), Formula (II) or Formula (III), or its geometric isomer, enantiomer or diastereomer to a subject in need thereof: wherein is a single or double bond, X is NCH3 or CH2, Y is null, O or N, Z is O or N, R1 is H, OH, and R2 is null, H, C1-C8 alkyl, —(C?O)-alkyl, —(C?O)-aryl, —(C?O)-alkyl-aryl, —(C?O)-heteroaryl, cycloalkyl or heterocycloalkyl, which optionally substituted by one or more of —OH, —NO2, —NH2, —NR3R4, carbonyl, alkoxyl, alkyl or —OCF3, wherein R3 and R4 independently are H, alkyl, O2CH3, —(C?O)—CH3 or (C?O)—NH2.

Abstract: A method for treating an autoimmune neurological disease and/or a neurodegenerative disease is provided. The method includes administering an effective amount of at least one compound having Formula (I), Formula (II) or Formula (III), or its geometric isomer, enantiomer or diastereomer to a subject in need thereof: wherein is a single or double bond, X is NCH3 or CH2, Y is null, O or N, Z is O or N, R1 is H, OH, and R2 is null, H, C1-C8 alkyl, —(C?O)-alkyl, —(C?O)-aryl, —(C?O)-alkyl-aryl, —(C?O)-heteroaryl, cycloalkyl or heterocycloalkyl, which optionally substituted by one or more of —OH, —NO2, —NH2, —NR3R4, carbonyl, alkoxyl, alkyl or —OCF3, wherein R3 and R4 independently are H, alkyl, —SO2CH3, —(C?O)—CH3 or —(C?O)—NH2.

Abstract: A method for treating an autoimmune neurological disease and/or a neurodegenerative disease is provided. The method includes administering an effective amount of at least one compound having Formula (I), Formula (II) or Formula (III), or its geometric isomer, enantiomer or diastereomer to a subject in need thereof: wherein is a single or double bond, X is NCH3 or CH2, Y is null, O or N, R1 is H, OH, and R2 is null, H, C1-C8 alkyl, —(C?O)-alkyl, —(C?O)-aryl, —(C?O)-alkyl-aryl, —(C?O)-heteroaryl, cycloalkyl or heterocycloalkyl, which optionally substituted by one or more of —OH, —NO2, —NH2, —NR3R4, carbonyl, alkoxyl, alkyl or —OCF3, wherein R3 and R4 independently are H, alkyl, —SO2CH3, —(C?O)—CH3 or —(C?O)—NH2.

Abstract: A method of synthesizing tungsten carbide nanorods, the method comprising: mixing tungsten oxide (WO3) nanorods with a carbon source to obtain precursors; and calcining the precursors to obtain tungsten carbide nanorods, without use of any catalyst. A catalyst of metal nanostructures supported on tungsten carbide nanorods.

Abstract: A method of synthesizing tungsten carbide nanorods, the method comprising: mixing tungsten oxide (WO3) nanorods with a carbon source to obtain precursors; and calcining the precursors to obtain tungsten carbide nanorods, without use of any catalyst. A catalyst of metal nanostructures supported on tungsten carbide nanorods.

Abstract: A diindenothiophene derivative of the following formula (1) is disclosed: wherein each of G1, G2, G3 and G4 is independently an unsubstituted or substituted C6-C40-aromatic group or a C1-C40-aliphatic group; A is an electron-withdrawing group; and D is an electron-donating group. The inventive diindenothiophene derivatives can be used in a dye-sensitized solar cell.

Abstract: A diindenothiophene derivative of the following formula (1) is disclosed: wherein each of G1, G2, G3 and G4 is independently an unsubstituted or substituted C6-C40-aromatic group or a C1-C40-aliphatic group; A is an electron-withdrawing group; and D is an electron-donating group. The inventive diindenothiophene derivatives can be used in a dye-sensitized solar cell.

Abstract: An herbal extract which induces immune cells to produce interferon and activates Toll-like receptors and a preparation method thereof are provided. The herbal extract is extracted from an effective amount of raw material including Glycyrrhizae Radix, Bupleuri Radix, Scutellariae Radix, Schisandrae Fructus and Paeoniae Rubra Radix. Glycyrrhizae Radix, Bupleuri Radix, Scutellariae Radix, Schisandrae Fructus and Paeoniae Rubra Radix have a weight ratio of 1-5:1-5:1-5:1-3:1-3.